However, it might be difficult for Apple to leverage its Watch to broaden its roster of long-term health partners if it's doling out false positives: US consumers already cost the health system a whopping
annually in unnecessary tests and treatments, and healthcare entities are going to look for ways to mitigate—not compound—these sky-high costs. deals with major insurers like Aetna for Watch-driven wellness programs, and if the tech giant wants to retain payers' attention, it'll need to prove the effectiveness of its other health features—like its blood oxygen measurement—in mitigating spending.
Until big tech companies earn FDA clearance for more of their wearables' health features, we expect health entities to opt for more verified and healthcare-focused tools in their initiatives. Apple isn't the only tech giant vying for research partnerships: Fitbit a virtual study to validate the use of its heart monitoring tech in detecting atrial fibrillation in May.
However, we expect that research institutions, for instance, will be more wary about using big tech-developed wearables that haven't been authenticated clinically. Instead, they may be inclined to partner with more affordable and clinically specific tools: For example, Mayo Clinic currently
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
ソース: BusinessInsider - 🏆 729. / 51 続きを読む »
ソース: BusinessInsider - 🏆 729. / 51 続きを読む »
ソース: BusinessInsider - 🏆 729. / 51 続きを読む »
ソース: BusinessInsider - 🏆 729. / 51 続きを読む »